Swedish Pharmaceuticals & Biotech Most Popular Stocks

Swedish Orphan Biovitrum

Market Cap: SEK 128.9b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Camurus

Market Cap: SEK 28.0b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

BioArctic

Market Cap: SEK 26.8b

Develops biological drugs for patients with central nervous system disorders in Sweden.

AddLife

Market Cap: SEK 17.0b

Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.

Bonesupport Holding

Market Cap: SEK 13.1b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Vitrolife

Market Cap: SEK 12.6b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

BioGaia

Market Cap: SEK 11.5b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

MedCap

Market Cap: SEK 7.1b

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.

Swedencare

Market Cap: SEK 4.0b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

Hansa Biopharma

Market Cap: SEK 3.0b

A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.

Vicore Pharma Holding

Market Cap: SEK 2.8b

A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.

Flerie

Market Cap: SEK 2.8b

A venture capital firm specializing in early-stage investments.

Saniona

Market Cap: SEK 2.3b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.

Egetis Therapeutics

Market Cap: SEK 2.1b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

Diamyd Medical

Market Cap: SEK 1.9b

Develops precision medicine therapies for the treatment of autoimmune diabetes.

Cereno Scientific

Market Cap: SEK 1.8b

A clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases in Sweden and internationally.

BioInvent International

Market Cap: SEK 1.4b

A clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.

Devyser Diagnostics

Market Cap: SEK 1.3b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Medivir

Market Cap: SEK 1.3b

A pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Sweden, the Nordic region, rest of Europe, and internationally.

BICO Group

Market Cap: SEK 1.2b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

Genovis AB (publ.)

Market Cap: SEK 1.1b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

Curasight

Market Cap: DKK 728.4m

Develops therapeutic and diagnostic solutions for the treatment of cancer.

Xspray Pharma

Market Cap: SEK 1.0b

A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.

Cantargia

Market Cap: SEK 1.0b

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

SynAct Pharma

Market Cap: SEK 981.1m

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

Orexo

Market Cap: SEK 837.8m

A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally.

Cinclus Pharma Holding

Market Cap: SEK 833.0m

A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.

Hamlet BioPharma

Market Cap: SEK 746.3m

Engages in the development of drugs for the treatment and prevention of cancer in Sweden.

Dicot Pharma

Market Cap: SEK 721.4m

Engages in the development of pharmaceutical products in Sweden.

Infant Bacterial Therapeutics

Market Cap: SEK 672.9m

Operates as a clinical stage pharmaceutical company develops and markets drugs to prevent serious neonatal diseases affecting premature infants in Sweden.

Moberg Pharma

Market Cap: SEK 542.9m

A pharmaceutical company, develops and commercializes medical products primarily in Sweden.

Enzymatica

Market Cap: SEK 500.0m

A life science company, develops and sells medical devices for infection-related diseases.

Cessatech

Market Cap: DKK 345.5m

A pivotal-stage pediatric biotech company, develops specialty hospital medicines for children in Denmark.

FluoGuide

Market Cap: SEK 493.7m

A clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark.

Oncopeptides

Market Cap: SEK 422.7m

A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.

Corline Biomedical

Market Cap: SEK 393.2m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications in Sweden.